Kane Biotech Inc.

Kane Biotech Inc.
Stock Exchange Toronto Ventures Stock Exchange
EPS
CAD0.04
Market Cap
CAD10.01 M
Shares Outstanding
80.11 M
Public Float
51.64 M

Profile

Address
196 Innovation Drive
Winnipeg Manitoba R3T 2N2
Canada
Employees -
Website http://www.kanebiotech.com
Updated 07/08/2019
Kane Biotech, Inc. is a biotechnology company, which engages in the development and commercialization of products to prevent and remove biofilms. It uses a patent protected technology based on molecular mechanisms of biofilm formation and methods for finding compounds that inhibit or disrupt biofilms. Its trademarks include StrixNB, DispersinB, Aledex, blueste, AloSer, coactive, and Kane.

Financials

View All

Rashieda Gluck
Director
R. Philip Renaud
Chairman